Exhibit 99.2
 
 
AURINIA PHARMACEUTICALS INC.
Report of Voting Results

This report is filed pursuant to Section 11.3 of National Instrument 51-102 and relates to the results of voting at the annual general meeting of Aurinia Pharmaceuticals Inc. (the “Company”) held on June 21, 2018.


Description of Matter
Outcome of Vote
   
Resolution to fix the number of directors at eight.
Resolution passed by requisite majority.
 
Details of the voting by proxy are as follows:
 
Total shares voted in favour: 23,118,904 (99.49%)
 
Total shares against: 118,500 (0.51%)
   
Resolution to elect the management nominees as directors of the Company.
All nominees proposed by management were elected to serve as directors of the Company until its next annual general meeting.
 
Details of the voting by proxy are as follows:
 
Name
Votes in
Favour
Votes
Withheld
Richard Glickman
23,090,241
(99.37%)
147,163
(0.63%)
Lorin J. Randall
23,115,598
(99.48%)
121,806
(0.52%)
Benjamin Rovinski
23,100,651
(99.41%)
136,753
(0.59%)
David Jayne
23,113,953
(99.47%)
123,451
(0.53%)
Hyuek Joon Lee
23,078,908
(99.32%)
158,496
(0.68%)
George Milne
22,947,304
(98.75%)
290,100
(1.25%)
Joseph Hagan
23,052,474
(99.20%)
184,930
(0.80%)
Michael Hayden
23,109,574
(99.45%)
127,830
(0.55%)
 

 
Resolution to appoint PricewaterhouseCoopers LLP, Chartered Professional Accountants as auditors of the
Company until its next annual general meeting, at a remuneration to be fixed by the directors.
Resolution passed by requisite majority.
 
Details of the voting by proxy are as follows:
 
Total shares voted in favour: 66,062,104 (98.79%)
 
Total shares withheld: 807,663 (1.21%)
 
 
DATED this 22nd day of June, 2018
AURINIA PHARMACEUTICALS INC.



By:    /s/ Dennis Bourgeault  
  Name:  Dennis Bourgeault   
  Title:  Chief Financial Officer   
 
 
- 2 -